JPM-Thematics-Gen.Therap.C(acc)USD
LU2098775203
JPM-Thematics-Gen.Therap.C(acc)USD/ LU2098775203 /
| NAV2024-04-25 |
Chg.-2.7400 |
Type of yield |
Investment Focus |
Investment company |
| 76.5800USD |
-3.45% |
reinvestment |
Equity
Worldwide
|
JPMorgan AM (EU) ▶ |
Investment strategy
To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
Will invest in equities of companies that have been identified by the Investment Manager as being involved in research, development, production or marketing of genetic therapies and their associated businesses anywhere in the world, including emerging markets. The Investment Manager supervises and monitors the theme identification and portfolio construction process and actively selects securities for the Sub-Fund"s portfolio. At least 90% of companies purchased will be analysed against the theme.
Investment goal
To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Health / Pharma |
| Benchmark: |
MSCI All Country World Index (Total Return Net) |
| Business year start: |
07-01 |
| Last Distribution: |
- |
| Depository bank: |
J.P. Morgan SE - Zweigniederlassung Luxemburg |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, Luxembourg |
| Fund manager: |
Yazann Romahi, Aijaz Hussain |
| Fund volume: |
611.73 mill.
USD
|
| Launch date: |
2020-01-17 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
0.00% |
| Max. Administration Fee: |
0.36% |
| Minimum investment: |
10,000,000.00 USD |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Assets
| Stocks |
|
99.54% |
| Mutual Funds |
|
0.46% |
Countries
| United States of America |
|
75.24% |
| Switzerland |
|
9.84% |
| Japan |
|
5.55% |
| Germany |
|
2.16% |
| Australia |
|
1.82% |
| China |
|
1.26% |
| France |
|
1.22% |
| Netherlands |
|
0.73% |
| Taiwan, Province Of China |
|
0.71% |
| Korea, Republic Of |
|
0.57% |
| Singapore |
|
0.24% |
| United Kingdom |
|
0.22% |
| Others |
|
0.44% |
Branches
| Pharma/Biotechnology |
|
87.68% |
| Healthcare services |
|
11.15% |
| Healthcare appliances |
|
0.68% |
| Others |
|
0.49% |
